A Pilot Phase II Multi Center Study of Gemcitabine and Nab-paclitaxel (Abraxane) as Preoperative Therapy for Potentially Operable Pancreatic Cancer.
Phase of Trial: Phase II
Latest Information Update: 19 Jun 2015
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Pancreatic cancer
- Focus Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 16 Jun 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 13 Feb 2014 Planned End Date changed from 1 Mar 2016 to 1 Dec 2014 as reported by ClinicalTrials.gov.